Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
---|---|---|---|---|---|---|
2021 | Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelines | Teng, W; Chang, TT; Yang, HI ; Peng, CY; Su, CW; Su, TH; Hu, TH; Yu, ML; Yang, HC; Wu, JC | Hepatology international 15, 1421-1430 | |||
2019 | Taiwan consensus statement on the management of chronic hepatitis B. | Chien, RN; Kao, JH; Peng, CY; Chen, CH; Liu, CJ; Huang, YH; Hu, TH; Yang, HI ; Lu, SN; Ni, YH; Chuang, WL; Lee, CM; Wu, JC; Chen, PJ; Liaw, YF | JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION 118(1 Pt 1), 7-38 |